Clinical Trials Browser

Interventional × Ultrasonic Waves × 90 days × Clear all

NCT04921787 2026-04-23

EXHITENTRE

Phase NA Active not recruiting

Lymphoma, Follicular, Opioid-Related Disorders, Substance-Related Disorders